The Dutch Organization for Health Research and Development launched HTA Methodology Program for 2021-2024

31

Mar 2021

The 2021-2024 HTA Methodology Program aims to develop HTA-related research designs, methods of analysis, and outcome measures for existing care and care innovations to improve research into the efficiency of care. The Ministry of Health, Welfare and Sport makes a maximum of €1,500,000 annually to implement the Program.

The HTA Methodology program for 2021-2024 will focus on methodologies for the assessment of a wide variety of innovations, such as genetic testing, implants, medicines, medical aids, and e-health, as well as for interventions that have existed for a much longer time and that have now been given a new light.

The Program has the following targets:

  • The framework for implementation of the development of methodology that is useful for researchers, innovators, insurers, healthcare providers, and the government to evaluate the value of existing and new healthcare interventions in an appropriate manner
  • Contribution to the decision-making about the appropriate use of medical innovations and their inclusion into the basic insurance package and the implementation of existing care
  • Contribution to the further development of innovative research designs and analysis techniques that enable assessment in situations with, for example, little evidence data available
  • The further development of outcome measures that can also be used to assess the effectiveness of care in situations where the main concern is improving the well-being of patients, such as a long-term care
  • A learning guide in the form of a structured overview to help innovators, healthcare providers, and researchers to determine which research designs, analysis methods, and outcome measures are appropriate

Program includes:

  • Round 1 (2021): knowledge gap analysis and elaboration of the Program
  • Round 2 (2022): development of a learning guide
  • Round 3 (2023): mid-term evaluation of a learning guide
  • Round 4 (2024): update of a learning guide

The final evaluation of the HTA Program outcomes is scheduled for 2026.

The full details in Dutch can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

01

Apr 2021

In March 2021, the National Institute for Health Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned sacral nerve stimulation and magnetic sphincter augmentation device for fecal incontinence treatment, patch augmentation surgery for rotator cuff repair, in-vitro diagnostics, and eHealth. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and inform National Institute for Health and Care Excellence (NICE) guidance.

Read more

18

Mar 2021

The Dutch Healthcare Institute (ZIN), in collaboration with the Ministry of Health, Welfare and Sport (VWS), Dutch Health Authority (NZa), and Health and Youth Care Inspectorate (IGJ), implemented an extension of existing digital healthcare innovation programs called "ZorgZandbak" to demonstrate how digital care could become an integral part of regular care.

Read more

15

Mar 2021

In March 2021, the new mini-HTAs of five technologies were initiated in Norway: Harpoon - transapical neochordae device, tricuspidal clip, portable hand-held spirometry, CGM device and insulin pump, and portable spirometry device. The final mini-method assessment will be published in the National Database for Mini-HTA.

Read more

12

Mar 2021

On February 23, 2021, NHSX launched Digital Technology Assessment Criteria for health and social care (DTAC), the new national criteria designed to provide suppliers and healthcare organizations a clear direction on building and buying good digital health technologies. DTAC will apply to all types of digital health technologies, from public-facing health apps to digital systems used within hospitals. The assessment criteria are focused on five areas: digital technologies will receive a pass or fail in four categories - clinical safety, data protection, technical security and interoperability, and a score on usability and accessibility.

Read more

08

Mar 2021

In late February 2021, eleven out of fifteen needed members and three observers of the Treatment Council (Behandlingsråd) were appointed in Denmark. The Treatment Council is a new model for assessing treatment methods and health technologies, expected to become fully operational in early 2021. Earlier in February 2021, the final method and process framework of the Treatment Council was approved.

Read more